##common.pageHeaderLogo.altText##

Vol. 3 No. 4 (2023)

Sustained Ventricular Tachycardia in Acute Coronary Syndrome with ST Segment Elevation: Incidence, Predictive Factors and Related Mortality.

Clinical Medicine And Health Research Journal, Vol. 3 No. 4 (2023), 18 August 2023 , Page 505-512
https://doi.org/10.18535/cmhrj.v3i4.216

Abstract

Background: Sustained Ventricular Tachycardia is the most serious complication; in acute coronary syndrome with ST segment elevation, several international studies have reported incidence and predictive factors of severe ventricular arrhythmias, without identifying sustained ventricular tachycardia separately; also, its epidemiological data is lacking in Algeria.


Aims: The main objective of our study is the determination of the frequency of sustained ventricular tachycardia in acute coronary syndrome with ST segment elevation, the secondary objective was the analysis of predictive factors of this arrhythmia, and related mortality.


Methods and materials:  In this prospective study, conducted in the cardiology department of Hussein Dey hospital (Algiers-Algeria), 467 patients with acute coronary syndrome with elevated ST segment (87 women and 380 men) were enrolled between 28 February 2014 and 16 July 2015. The average age is 60 ± 13 years; at admission, a Holter recorder was attached for continuous ECG monitoring during 48 hours


Kruskal’s ANNOVA or H tests were used for comparison of quantitative variables, χ2 test or Fisher’s exact test, were used for qualitative variables, all tests were performed with 1st species risk of 5%.


Results:  The frequency of Sustained Ventricular Tachycardia is 3.6 % (17 patients), CI 95%: [1.9%-5.3%], multivariate analysis identified the following independent predictors: low diastolic blood pressure, severe coronary artery lesions, Elevated high sensitive troponin concentrations more than 5ng/ml.


The risk of mortality expressed by Hazard Ration (HR) is 6. (CI95%: [1.7-21], p = 0.005); the predictors of mortality are: occurrence of ventricular fibrillation and low diastolic blood pressure.


Conclusion: Sustained Ventricular tachycardia is the most serious complication during acute coronary syndrome with elevated ST segment, its predictive factors according to our study are: low diastolic blood pressure, severe coronary lesions, Elevated high sensitive troponin concentrations more than 5ng/ml, its occurrence increases the risk of hospital mortality.

Keywords:
  • Keywords: Acute Coronary Syndrome, Sustained Ventricular Tachycardia, Severe Coronary Artery Lesions

How to Cite

ZOUZOU, H. (2023). Sustained Ventricular Tachycardia in Acute Coronary Syndrome with ST Segment Elevation: Incidence, Predictive Factors and Related Mortality. Clinical Medicine And Health Research Journal, 3(4), 505–512. https://doi.org/10.18535/cmhrj.v3i4.216

Download Citation

References

  • A V Ghuran, A J Camm. Ischaemic heart disease presenting as arrhythmias. British Medical Bulletin 2001; 59: 193–210.
  • Steg PG, Goldberg RJ, Gore JM et al. Baseline characteristics, management practices and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90: 358-63.
  • Tachapong Ngarmukos, Charn Sriratanasthavorn, Buncha Sansaneevithayakul. Cardiac Arrhythmias in Thai Acute Coronary Syndrome Registry. J Med Assoc Thai 2007; 90 (Suppl 1): 58-64.
  • Patrizia Cricri, Lukas D. Trachsel, Petter Muller. Incidence and time frame of life-threatening arrhythmias in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Swiss Med Weekly. 2012; 142.
  • Mehta RH1, Starr AZ, Lopes RD. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009 May 6;301(17):1779-89.
  • Rajendra H. Mehta, Kishore J. Harjai, Lorelei Grines. Sustained Ventricular Tachycardia or Fibrillation in the Cardiac Catheterization Laboratory Among Patients Receiving Primary Percutaneous Coronary Intervention Incidence, Predictors, and Outcomes. J Am Coll Cardiol 2004;43:1765–72
  • Hersi AS, Alhabib KF, Alfaleh HF. Incidence of ventricular arrhythmia and associated patients outcomes in hospitalized acute coronary syndrome patients in Saudi Arabia: findings from the registry of the Saudi project for assessment of acute coronary syndrome (SPACE). HMVJC Novembre 2012.
  • Renato D. Lopes, Laine E. Elliott, Harvey D. White. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. European Heart Journal (2009) 30, 2019–2028.
  • Marina M Demidova, J Gustav Smith, Carl-Johan Höijer, Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated with primary PCI. European Heart Journal. Acute Cardiovasc Care. 2012 Dec; 1(4): 302–311.
  • Álvaro Avezum, Leopoldo S. Piegas, Robert J. Goldberg. Magnitude and Prognosis Associated with Ventricular Arrhythmias in Patients Hospitalized with Acute Coronary Syndromes 267 (from the GRACE Registry). December 15, 2008 Volume 102, Issue 12, Pages 1577– 1582.
  • Piccini JP1, Hranitzky PM, Kilaru R. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Am J Cardiol. 2008 Dec 1;102(11):1427-32.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information